1. Field of the Invention
The present invention relates to alcoholic foam compositions.
2. Discussion of the Background
Disinfectants are used to combat pathogenic microorganisms such as bacteria, viruses, spores, fungi, etc. The use of disinfectants is unavoidable in many regions or the use is expressly required by the legislators in many countries.
Disinfectants are usually classified according to their area of application and, depending on intended use, a distinction is made between antiseptics for wound, skin, stools and sputum disinfection as well as instruments disinfection, laundry and surface disinfectants, and especially also skin and hand disinfectants.
The area of application of the aforesaid disinfectants is medically indicated and they are used for prevention of infections in hospitals, doctors' and dentists' offices, in public areas such as schools, kindergartens, nursing institutions, retirement homes, sanatoriums, etc., and also in sports facilities and other places in which infections can be transmitted. Besides the use of disinfectants in the food industry and pharmaceutical industry, they are in general use not only at the workplace or in the home, but also in service industries such as laundries and kitchens, where the products are delivered directly to patients or consumers.
Demonstration of the effectiveness of such disinfecting agents for one or more of the aforesaid areas, of applications is achieved by thorough testing of these agents on the basis of standardized test methods, such as the guidelines of the German Association for Hygiene and Microbiology (DGHM) in Germany or the guidelines of the French Association for Standardization (AFNOR) in France. Examples of further standards are listed below:
In the capacity of pharmaceuticals, antiseptics are further subject to legally governed approval and registration procedures.
For example, as can be seen from German Patent DE 4328828 A, various methods are available for achieving hand disinfection. Explicitly mentioned therein are the alcoholic hand disinfection methods that are standard in Germany as well as the scrub methods of hand disinfection. Products intended for hand disinfection among other purposes must satisfy at least the minimum requirements indicated in the aforesaid standards if they are to be certified as conforming with those standards and included as preparations in the disinfection list of the DGHM.
Commercially available disinfectants, especially skin and hand disinfectants, are usually composed of alcohol or mixtures of alcohols, optionally of active ingredients, which remain on the skin after evaporation of the alcohol components and which can be, for example, nonvolatile antimicrobial substances and/or common skin-care substances, and possibly other auxiliaries. If the alcohol component is used alone as the antimicrobial agent, the alcohol concentration in the product is to be chosen such that a disinfectant effect is assured even after evaporation of part of the alcohol. In this connection, it is known that this is the case for ethanolic compositions having an alcohol concentration of at least 52 wt %.
To address the disadvantages of alcoholic disinfectant solutions applied for skin and hand disinfection, thickeners have been added to such disinfectant solutions in order to increase the viscosity of these agents. Disadvantages include especially the difficulty of dosing due to the fact that the needed quantity of disinfectant often cannot be distributed uniformly over the skin or the hands and that aqueous alcohol solutions drip very easily from the hands. An example for added thickeners is found in European Patent EP 0604848 B, wherein the subject matter is a fast-drying disinfectant composition. As thickener there is described a combination of carboxyvinyl polymers and hydroxypropylmethylcellulose, wherein the total weight of the two components in the disinfectant composition is not greater than 3 wt %.
Also known are antimicrobial alcoholic gel compositions for skin and hand disinfection containing moisturizers and skin-care substances, as described in, for example, U.S. Pat. No. 4,956,170. In these compositions, cross-linked partly neutralized or neutralized acrylic acid polymers are used as thickeners. The antibacterial agent used in these compositions is 60 to 75 wt % of alcohol such as ethanol, isopropyl alcohol or mixtures thereof. Regarding the emollients contained in these gel compositions, especially petrolatum and other mineral-oil products that can be used in cosmetic preparations, as well as further hydrophobic constituents that can be used safely not only in cosmetics but also in disinfectants, it has been found that the use of such constituents in alcoholic gel compositions having high alcohol concentrations is highly detrimental to the stability of such gels, because the gels lose their viscosity and therefore their stability in the course of time during storage, and the compositions deliquesce. In general, it has been found that the gel stability suffers with increasing alcohol concentration, especially at alcohol concentrations higher than 60 wt %.
Such high alcohol concentrations, especially in gel compositions containing alcohol as the sole active component, are unavoidable, however, in order that such agents can also be certified as disinfectants for hand disinfection.
German Patent DE 10132382 discloses a simple, economic production method for the production of stable disinfectant hand-care and skin-care gels having high alcohol concentration, permitting the production of disinfectant hand-care gels that contain care components, that satisfy the standards
among others directly without further additional antimicrobial adjuvants, and that also have a hepatitis B activity. Although it has been shown that the application of a disinfectant agent in gel form is to be preferred to the application of a disinfectant agent in liquid form, especially as regards its drying-out tendency, such disinfectant alcoholic gel compositions nevertheless have the disadvantage that they must lose their gel structure upon being applied on the skin, in order to ensure uniform wetting of the skin areas and thus a safe disinfectant action.
Also known are alcoholic cleaning foam compositions, which are dispensed by commercially available pump-foam systems, which are to be found mainly in sanitary units of hospitals, doctors' and dentists' offices, schools, kindergartens and nursing institutions, such as old-age homes, sanatoriums, etc. The alcohol concentration of such foam compositions is only around 40 wt %, however, because the instability of the foams increases at higher alcohol concentrations. This can also be regarded as the reason why the advantageous form of application by means of foam, which is even more manageable than alcoholic gels, has not yet been considered for disinfectants, especially not for skin and hand disinfection, because of the low alcohol concentration of the products that have been commercially available heretofore.
It is an object of the present invention to provide an alcoholic foam composition that can be dispensed as pump foam, particularly via standard pump-foam systems, to the consumer for disinfection purposes, preferably for skin and hand disinfection.
It is another object of the present invention to provide an alcoholic foam that is stabilized in such a way that alcoholic foam having an alcohol concentration of at least 52 wt %, especially greater than 60 wt % of alcohol can be dispensed in order to ensure safe disinfection, especially skin and hand disinfection.
This and other objects have been achieved by the present invention the first embodiment of which includes an alcoholic foam composition, comprising:
wherein the surface tension of component b) lies in the range of ±15 dyn/cm of the surface tension of component a) or corresponds to the surface tension of component a), and
wherein the sum of components a) to f) is 100 wt % relative to the total quantity of the foam composition.
The present invention provides an alcoholic foam composition for disinfection, especially a pump-foam formulation, which contains the components
It was completely surprising that such alcoholic foam compositions, which preferably are suitable for skin and hand disinfection and which contain at least 52 wt % relative to the total quantity of the foam composition, can be dispensed as foam via standard pump-foam systems, without suffering spontaneous foam breaking because of the high alcohol concentration in the composition. In particular, it would have been expected of such high alcohol concentrations that the alcohol components of such foam compositions would act merely as a solvent at an alcohol concentration of higher than 50 wt %, whereby the surface-active effects of the surfactants and accordingly their foaming ability also would be lowered. Such effects were not observed, however. To the contrary, it was found that stable voluminous foams for disinfection purposes could be produced with the foam compositions according to the present invention in standard pump-foam systems.
According to the present invention, the surface tension of component b) preferably lies in the range of ≧20 to ≦40 dyn/cm. The surface tension of component b) includes all values and subvalues therebetween, especially including 22, 24, 26, 28, 30, 32, 34, 36 and 38 dyn/cm.
Preferably, the alcoholic foam composition contains, as component a), alcohols of the general formula
R—OH
in which R denotes an aliphatic straight-chain or branched hydrocarbon group that has 1 to 8 carbon atoms and that can be contained alone or in mixtures in the foam according to the present invention.
Examples of such alcohols are methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, isobutyl alcohol, tert-butyl alcohol, the amyl alcohols, 1-, 2-, 3-pentanol or neopentyl alcohol as well as 1-hexanol, ethanol being particularly preferred as component a).
Preferably, the foam composition contains at least 52 to 99 wt %, preferably 55 to 96 wt % and especially more than 65 wt % of ethanol. The amount of ethanol includes all values and subvalues therebetween, especially including 55, 60, 65, 70, 75, 80, 85, 90 and 95 wt %. As regards the disinfectant action, it is particularly advantageous for the alcoholic foams according to the present invention to contain more than 80 wt % of alcohol.
As component b), the foam compositions according to the present invention can contain respectively a surfactant or surfactant mixture, with the proviso that the surface tension of the surfactant or of the surfactant mixture contained in the foam composition lies within the range of ±15 dyn/cm of the surface tension of component a), meaning the alcohol component, or corresponds to the surface tension of component a).
Every surfactant or surfactant mixture that satisfies the foregoing proviso is suitable as component b) of the foam compositions. The total quantity of the surfactant or surfactant mixture is 0.5 to 20, preferably 1 to 10 and particularly preferably 2 to 5 wt % relative to the total quantity of the foam composition. The amount of surfactant or surfactant mixture includes all values and subvalues therebetween, especially including 1, 2, 4, 6, 8, 10, 12, 14, 16, and 18 wt %
Such surfactants are, among other substances, silicone compounds, such as dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones as well as silicone compounds modified by amino, fatty acid, alcohol, polyether, epoxy, fluoro, glycoside and or alkyl groups. Preferred as silicone compounds according to the present invention are polysiloxane-polyether copolymers [INCI(CFTA): dimethicone copolyol], which are available from the company named Goldschmidt AG of Essen under the trade name ABIL®, especially polysiloxane-polyether copolymers of the B 88 product family, such as ABIL® B 8843, ABIL® B 8851, ABIL® B 8852, ABIL® B 8863, ABIL® B 88183 and ABIL® B 88184. Particularly preferably, the foam compositions according to the present invention contain, as component b), polysiloxane-polyether copolymers available under the trade name ABIL® B 8832 (bis-PEG/PPG-20/20 dimethicone).
As further suitable surfactants or surfactant mixtures there can be mentioned the group of fluoro surfactants, which can be present as component b) in the foams, either alone or as mixture of various fluoro surfactants, especially also as mixtures with polysiloxane-polyether copolymers. Such suitable surfactants are, for example, tetraalkylammonium perfluoroalkylsulfonates, preferably the tetraethylammonium perfluorooctanesulfonate that is commercially available under the trade name FLUORTENSIDE FT-248.
Furthermore, the foam compositions contain, as component c), at least one polyalkylene glycol, which can be present preferably in proportions of 0.01 to 3, especially 0.01 to 0.2 and particularly preferably 0.05 to 0.2 wt % relative to the total quantity of the foam composition. The amount of polyalkylene glycol includes all values and subvalues therebetween, specially including 0.05, 0.1, 0.5, 1, 1.5, 2, and 2.5 wt %. Preferred polyalkylene glycols according to the present invention are in particular polyethylene oxide homopolymers with a molecular weight of 100,000 to 8,000,000, which are available as commercial products on the market under the trademark Polyox®, such as Polyox® WSR N-10, Polyox® WSR N-80 (PEG-5M), Polyox® WSR N-750 (PEG-7M), Polyox® WSR N-3000 (PEG-14M), Polyox® WSR N-3333, Polyox® WSR-205 (PEG-14M), Polyox® WSR-1105, Polyox®) WSR N-12K, Polyox® WSR N-60K (PEG-45M) and Polyox® WSR-301.
The foam compositions contain optionally at least one foam stabilizer, which is present as component d) in the foam in a proportion of 0.01 to 20 wt %, preferably 0.5 to 3 wt % relative to the total quantity of the foam composition. The amount of foam stabilizer includes all values and subvalues therebetween, especially including 0.05, 0.1, 0.5, 1, 2, 4, 6, 8, 10, 12, 14, 16 and 18 wt %. Examples of suitable foam stabilizers are polysaccharides, especially xanthan gum, guar-guar, agar-agar, alginates and tyloses, cellulose ethers, such as carboxymethylcellulose, ethylcellulose, hydroxypropylcellulose, methylcellulose, cellulose mixed ethers, such as carboxymethylhydroxyethylcellulose, ethylhydroxyethylcellulose, methoxyhydroxyalkylcelluloses, methylhydroxyalkylcelluloses, such as methylhydroxyethylcellulose, methylhydroxypropylcellulose, methylhydroxybutylcellulose. Preferred according to the present invention are alkylcelluloses, especially methylcellulose and ethylcellulose that are commercially available under the trade names METHOCEL® and ETHOCEL®,
Besides water, the alcoholic foams according to the present invention can, if necessary, contain auxiliaries, adjuvants and/or active ingredients, such as dyes, solubilizers, complexing agents, sequestering agents, light-protecting filters or perfumes and scents, pH regulators, stabilizers, preferably cetearyl alcohol and/or hydrogenated castor oils, such as trihydroxystearin, preservatives, antioxidants and/or oil-based or water-based care components as component e), especially in standard proportions of preferably 0.05 to 5 wt % relative to the total weight of the foams. The amount of additional components includes all values and subvalues therebetween, especially including 0.05, 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4 and 4.5 wt %. These optional constituents of component e) can normally be present in proportions of 0 to 5 wt % relative to the total weight of the foam, but the person skilled in the art will choose the weight proportion of component e) such that no impairment of foam formation occurs.
In a preferred embodiment of the present invention, the foams contain 55 to 96 wt % of ethanol, 1 to 10 wt % of bis-PEG/PPG-20/20 dimethicone as silicone surfactant, 0.0 to 3 wt % of ethylcellulose polymer as stabilizer in combination with a PEG polymer, selected from PEG 7M to PEG 45M, preferably 0.05 to 2 wt %, whereby very effectively disinfecting foams with excellent stability are obtained in standard pump-foam systems. These amounts are given based on the total weight of the foam composition. The amount of ethanol includes all values and subvalues therebetween, especially including 60, 65, 70, 75, 80, 85 and 90 wt %. The amount of bis-PEG/PPG-20/20 dimethicone includes all values and subvalues therebetween, especially including 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8 and 9 wt %. The amount of ethylcellulose polymer includes all values and subvalues therebetween, especially including 0.1, 0.5, 1, 1.5, 2 and 2.5 wt %. The amount of PEG polymer includes all values and subvalues therebetween, especially including 0.1, 0.5, 1, and 1.5 wt %.
The alcoholic foams according to the present invention can be used particularly advantageously as disinfectants, for example as antiseptics for wound, skin, stools and sputum disinfection as well as instrument disinfection, as laundry and surface disinfectants and, particularly preferably according to the present invention, as skin and hand disinfectants.
The possible optional addition of nonvolatile antimicrobial substances in the foams is used in particular to intensify the disinfectant properties of the alcohol component. Of course, this depends on the area of application for which the foams are intended.
Antimicrobial substances can be present if necessary and can be used in the foams preferably alone or as combinations of a plurality of disinfectant active ingredients. Preferred are invert soaps, such as cationic surfactants, quaternary ammonium compounds, including benzalkonium chlorides or benzethonium chloride, biguanide compounds, such as chlorhexidine salts, phenol compounds, cresols, per compounds, iodine compounds, such as polyvidone iodine, organic acids, etc.
Nevertheless, the addition of such antimicrobial active ingredients may not be not necessary, since the foams have such a high alcohol concentration that the alcohol component functions as the disinfectant active ingredient on its own.
According to the present invention, care and/or moisturizing active ingredients, which can be contained optionally in the foams, especially for use of the foams as skin and hand disinfectants, are active ingredients that remain on the skin after evaporation of the alcohol component of the foam, for example standard skin-care substances such as dexpanthenol, glycerin, 1,2-propanediol, sorbitol, 1,3-butylene glycol, polyethylene glycol and other polyalcohols, hyaluronic acids, urea, chamomile extracts, alkoxylated cetyl alcohols and/or nonvolatile antimicrobial substances.
Since, (luring use as skin and hand disinfectants, the high alcohol proportion in the foams causes drying out of the treated skin areas during application, the use of at least one skin-care substance and/or one moisturizer is actually indispensable in daily practice with regard to frequent application of such disinfectants.
Also advantageous for the use of the foams for skin and hand disinfection is a constituent of natural plant tannins, such as ladies' mantle (Alchemilla xanthochlora, Rosaceae), tormentil rootstock (Potentilla erecta, Rosaceae), oak bark (Quercus petraea and Quercus robur, Fagaceae), ratanhia root (Krameria lappacea syn. K. triandra, Krameriaceae), witch hazel leaves (Hamamelis virginiana, Hamamelidaceae) and bilberries (Vaccinium myrtillus, Ericaceae) and natural synthetic tannins, such as Na bichlorophenylsulfamine, preferably in a proportion of 0.01 to 5 wt % of active substance relative to the total quantity of the foams. Of those, Hamamelis virginiana is particularly preferred as tannin. The amount of tannin includes all values and subvalues therebetween, especially including 0.05, 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4 and 4.5 wt %.
Despite their high alcohol concentration, the foams are characterized by very good stability, and so stable disinfectant foams, especially for skin and hand disinfection, are made available by the present invention. Even without further additional antimicrobial adjuvants, these foams satisfy the standards
among others, and in addition have hepatitis B activity. The latter effect especially is particularly advantageous, since the hepatitis B virus, just as the HIV virus that is responsible for the spread of AIDS (acquired immune deficiency syndrome), is communicable but is more stable and more infectious than the HIV virus. Thus, all precautions against transmission of hepatitis B are also preventive against the HIV virus (see Deutsches Ärzteblatt 84, No. 18, p. B 874 of 30 Apr. 1987).
Since the foams according to the present invention can have alcohol concentrations of >70 vol % or 60 wt % relative to the total quantity of the foam, they also have virus activity against “naked” or nonenveloped viruses, such as polioviruses and adenoviruses, and so such alcoholic foams are of particular interest as a form of application, especially for skin disinfection.
It is also advantageous that the foams according to the present invention can be dispensed in particular as pump foams via standard pump-foam systems to the consumers for disinfection purposes, preferably for skin and hand disinfection, especially because such pump foams can usually be manufactured inexpensively and simply as aerosol-base foams. Examples include the commercially available pump-foam systems of companies such as Airspray (Netherlands), Keltec (Netherlands), Ophardt (Germany), Brightwell (United Kingdom) and Supermatic (Switzerland).
The foam compositions of the present invention can be obtained by mixing components a) to c) and optionally d), e) and/or f).
Foam compositions preferred according to the present invention (all data in wt % relative to the total quantity of the foam composition):
Foam compositions preferred according to the present invention for skin and hand disinfection (all data in wt % relative to the total quantity of the foam composition):
German patent application 10 2004 062 775.4 filed, Dec. 21, 2004, is incorporated herein by reference.
Numerous modifications and variations on the present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein.
Number | Date | Country | Kind |
---|---|---|---|
10 2004 062 775 | Dec 2004 | DE | national |
Number | Name | Date | Kind |
---|---|---|---|
2054989 | Moore | Sep 1936 | A |
2559749 | Benning | Jul 1951 | A |
2597702 | Benning | May 1952 | A |
2599140 | Taub | Jun 1952 | A |
2855367 | Buck | Oct 1958 | A |
3131153 | Klausner | Apr 1964 | A |
3395214 | Mummert | Jul 1968 | A |
3708435 | Starkman | Jan 1973 | A |
3709437 | Wright | Jan 1973 | A |
3770648 | Mackles | Nov 1973 | A |
3787566 | Gauvreau et al. | Jan 1974 | A |
3824303 | Lanzet | Jul 1974 | A |
3928558 | Cheesman et al. | Dec 1975 | A |
3962150 | Viola | Jun 1976 | A |
3963507 | Kuramoto et al. | Jun 1976 | A |
4018364 | Wright | Apr 1977 | A |
4086178 | Walker | Apr 1978 | A |
4220665 | Klein | Sep 1980 | A |
4311695 | Starch | Jan 1982 | A |
4313978 | Stevens | Feb 1982 | A |
4336151 | Like et al. | Jun 1982 | A |
4440652 | Hunter | Apr 1984 | A |
4440653 | Briscoe | Apr 1984 | A |
4454060 | Lai et al. | Jun 1984 | A |
4478853 | Chaussee | Oct 1984 | A |
4511486 | Shah | Apr 1985 | A |
4559226 | Fogel et al. | Dec 1985 | A |
4567038 | Ciaudelli et al. | Jan 1986 | A |
4584189 | Leipold | Apr 1986 | A |
4613592 | Benzoni | Sep 1986 | A |
4714568 | Hurnik et al. | Dec 1987 | A |
4772592 | Benzoni | Sep 1988 | A |
4826828 | Wilmott et al. | May 1989 | A |
4839166 | Grollier et al. | Jun 1989 | A |
4839167 | Yamamoto et al. | Jun 1989 | A |
4857302 | Decker et al. | Aug 1989 | A |
4897262 | Nandagiri et al. | Jan 1990 | A |
4906459 | Cobb et al. | Mar 1990 | A |
4915934 | Tomlinson | Apr 1990 | A |
4919837 | Glack | Apr 1990 | A |
4956170 | Lee | Sep 1990 | A |
4956173 | Le Fur et al. | Sep 1990 | A |
4981678 | Tomlinson | Jan 1991 | A |
4983377 | Murphy et al. | Jan 1991 | A |
4986922 | Snow et al. | Jan 1991 | A |
4988453 | Chambers | Jan 1991 | A |
5015228 | Columbus et al. | May 1991 | A |
5043088 | Falla | Aug 1991 | A |
5047249 | Rothman et al. | Sep 1991 | A |
5073371 | Turner et al. | Dec 1991 | A |
5100658 | Bolich, Jr. et al. | Mar 1992 | A |
5104646 | Bolich, Jr. et al. | Apr 1992 | A |
5122541 | Eggensperger et al. | Jun 1992 | A |
5128123 | Brewster et al. | Jul 1992 | A |
5167950 | Lins | Dec 1992 | A |
5180584 | Sebag et al. | Jan 1993 | A |
5204099 | Barbier et al. | Apr 1993 | A |
D338585 | Bell | Aug 1993 | S |
5232691 | Lemole | Aug 1993 | A |
5256401 | Duckenfield | Oct 1993 | A |
5265772 | Bartasevich | Nov 1993 | A |
5266598 | Ninomiya et al. | Nov 1993 | A |
D343751 | Bell | Feb 1994 | S |
5288486 | White | Feb 1994 | A |
5290555 | Guthauser et al. | Mar 1994 | A |
D346332 | Kanfer | Apr 1994 | S |
5300284 | Wiechers et al. | Apr 1994 | A |
5314684 | Horoschak et al. | May 1994 | A |
5336497 | Guerrero et al. | Aug 1994 | A |
5352437 | Nakagawa et al. | Oct 1994 | A |
5362484 | Wood et al. | Nov 1994 | A |
5370267 | Schroeder | Dec 1994 | A |
5415811 | Wile | May 1995 | A |
5441178 | Wysocki | Aug 1995 | A |
5443236 | Bell | Aug 1995 | A |
5445288 | Banks | Aug 1995 | A |
5449137 | Bell | Sep 1995 | A |
5462688 | Lippman | Oct 1995 | A |
D365509 | Bell | Dec 1995 | S |
D365518 | Wysocki | Dec 1995 | S |
D365755 | Kanfer | Jan 1996 | S |
5484597 | Slavtcheff et al. | Jan 1996 | A |
5494533 | Woodin, Jr. et al. | Feb 1996 | A |
5523014 | Dolan | Jun 1996 | A |
5547662 | Khan et al. | Aug 1996 | A |
5549888 | Venkateswaran | Aug 1996 | A |
5558453 | Bell | Sep 1996 | A |
5567428 | Hughes | Oct 1996 | A |
5587358 | Sukigara | Dec 1996 | A |
5607980 | McAfee et al. | Mar 1997 | A |
5612324 | Guang Lin et al. | Mar 1997 | A |
5625659 | Sears | Apr 1997 | A |
5626853 | Bara et al. | May 1997 | A |
5629006 | Hoang | May 1997 | A |
5635462 | Fendler | Jun 1997 | A |
5635469 | Fowler et al. | Jun 1997 | A |
D383001 | Bell | Sep 1997 | S |
5662893 | George et al. | Sep 1997 | A |
5665332 | Mundschenk et al. | Sep 1997 | A |
D385795 | Wysocki | Nov 1997 | S |
5690921 | Lang et al. | Nov 1997 | A |
5693255 | Okamoto et al. | Dec 1997 | A |
5718353 | Kanfer | Feb 1998 | A |
5719113 | Fendler | Feb 1998 | A |
D392136 | Ross | Mar 1998 | S |
5725131 | Bell et al. | Mar 1998 | A |
5733535 | Hollingshead et al. | Mar 1998 | A |
5756077 | Syed et al. | May 1998 | A |
5767161 | Stroppolo et al. | Jun 1998 | A |
5776430 | Osborne et al. | Jul 1998 | A |
5789371 | Tracy et al. | Aug 1998 | A |
5824320 | Rouillard et al. | Oct 1998 | A |
D400799 | Bell | Nov 1998 | S |
5834516 | O'Lenick, Jr. | Nov 1998 | A |
5856347 | Hashiguchi et al. | Jan 1999 | A |
5863884 | Lafreniere | Jan 1999 | A |
5902778 | Hartmann et al. | May 1999 | A |
5906808 | Osborne | May 1999 | A |
D411456 | Mast | Jun 1999 | S |
5908619 | Scholz | Jun 1999 | A |
5919439 | Torgerson et al. | Jul 1999 | A |
5922663 | Gabriel et al. | Jul 1999 | A |
5928993 | Johansson | Jul 1999 | A |
5935587 | Cauwet et al. | Aug 1999 | A |
5944227 | Schroeder | Aug 1999 | A |
5951993 | Scholz | Sep 1999 | A |
5952290 | Li et al. | Sep 1999 | A |
5955408 | Kaiser | Sep 1999 | A |
5955416 | Baillely et al. | Sep 1999 | A |
D415343 | Maddox | Oct 1999 | S |
5972356 | Peffly et al. | Oct 1999 | A |
D416417 | Ross | Nov 1999 | S |
5980876 | Peffy | Nov 1999 | A |
5996851 | Dolan | Dec 1999 | A |
D418708 | Kanfer | Jan 2000 | S |
6019997 | Scholz et al. | Feb 2000 | A |
6022551 | Jampani et al. | Feb 2000 | A |
6039965 | Donian et al. | Mar 2000 | A |
D422828 | Kanfer | Apr 2000 | S |
6065639 | Maddox | May 2000 | A |
6086856 | Saferstein et al. | Jul 2000 | A |
6090395 | Asmus | Jul 2000 | A |
6117440 | Suh | Sep 2000 | A |
6130253 | Franklin et al. | Oct 2000 | A |
6183766 | Sine et al. | Feb 2001 | B1 |
6217885 | Roder et al. | Apr 2001 | B1 |
6255265 | Van Gunst | Jul 2001 | B1 |
6262128 | Stern et al. | Jul 2001 | B1 |
6265363 | Viscovitz | Jul 2001 | B1 |
6267946 | Barnhart | Jul 2001 | B1 |
6274124 | Vollhardt | Aug 2001 | B1 |
6277359 | Raths et al. | Aug 2001 | B1 |
6319958 | Johnson et al. | Nov 2001 | B1 |
6333039 | Fendler et al. | Dec 2001 | B1 |
6339165 | Endo et al. | Jan 2002 | B1 |
6342470 | Aronson | Jan 2002 | B1 |
6352701 | Scholz et al. | Mar 2002 | B1 |
6358914 | Gabriel et al. | Mar 2002 | B1 |
6376438 | Rosenberger et al. | Apr 2002 | B1 |
6383505 | Kaiser | May 2002 | B1 |
6383997 | McManus | May 2002 | B1 |
6410005 | Galleguillos et al. | Jun 2002 | B1 |
6423329 | Sine et al. | Jul 2002 | B1 |
6462002 | Saxena | Oct 2002 | B2 |
6471983 | Veeger et al. | Oct 2002 | B1 |
6472356 | Narula et al. | Oct 2002 | B2 |
6479442 | Berube | Nov 2002 | B1 |
6489275 | Veeger et al. | Dec 2002 | B1 |
6491840 | Frankenbach et al. | Dec 2002 | B1 |
6497864 | Samain et al. | Dec 2002 | B1 |
6518228 | Jorgensen | Feb 2003 | B1 |
6524494 | Hart et al. | Feb 2003 | B2 |
6524594 | Santora | Feb 2003 | B1 |
6528544 | Stern et al. | Mar 2003 | B2 |
6534069 | Asmus et al. | Mar 2003 | B1 |
6537952 | Hayward | Mar 2003 | B2 |
6551605 | Bondo | Apr 2003 | B2 |
6555508 | Paul et al. | Apr 2003 | B1 |
6562360 | Scholz | May 2003 | B2 |
6585711 | Asmus et al. | Jul 2003 | B1 |
6592880 | Jager | Jul 2003 | B1 |
6610315 | Scholz | Aug 2003 | B2 |
6617294 | Narula et al. | Sep 2003 | B2 |
6623744 | Asmus | Sep 2003 | B2 |
6638527 | Gott | Oct 2003 | B2 |
6641825 | Scholz | Nov 2003 | B2 |
6664256 | Oohkuchietal | Dec 2003 | B1 |
6664356 | Shih | Dec 2003 | B1 |
6666217 | Elsner | Dec 2003 | B2 |
6685952 | Ma et al. | Feb 2004 | B1 |
6689593 | Millis | Feb 2004 | B2 |
6696397 | Staats | Feb 2004 | B2 |
6703007 | Glenn, Jr. | Mar 2004 | B2 |
6706675 | Demson | Mar 2004 | B1 |
6709647 | Bhakoo | Mar 2004 | B2 |
6710022 | Kwetkat et al. | Mar 2004 | B1 |
6723689 | Hoang | Apr 2004 | B1 |
6730621 | Gott | May 2004 | B2 |
6759376 | Zhang | Jul 2004 | B2 |
6762158 | Lukenbach | Jul 2004 | B2 |
6777384 | Raths et al. | Aug 2004 | B2 |
6780826 | Zhang | Aug 2004 | B2 |
6794345 | Elsner et al. | Sep 2004 | B2 |
6797687 | Kischket et al. | Sep 2004 | B2 |
6805141 | Elsner et al. | Oct 2004 | B2 |
6815410 | Boutique | Nov 2004 | B2 |
6818603 | Aleles | Nov 2004 | B2 |
6846846 | Modak et al. | Jan 2005 | B2 |
6875539 | Ophardt | Apr 2005 | B2 |
6884763 | Willard | Apr 2005 | B2 |
6946120 | Wai-Chiu et al. | Sep 2005 | B2 |
6977082 | Seitz, Jr. et al. | Dec 2005 | B2 |
7081246 | Asmus et al. | Jul 2006 | B2 |
7141237 | Abram et al. | Nov 2006 | B2 |
7163916 | Allef et al. | Jan 2007 | B2 |
7164041 | Moore et al. | Jan 2007 | B1 |
7166435 | Rosenbloom | Jan 2007 | B2 |
7199090 | Koivisto | Apr 2007 | B2 |
7241452 | Veeger et al. | Jul 2007 | B2 |
7297675 | Allef et al. | Nov 2007 | B2 |
7393817 | Kwetkat et al. | Jul 2008 | B2 |
7530477 | Ophardt | May 2009 | B2 |
7547732 | Moore et al. | Jun 2009 | B2 |
7566460 | Asmus | Jul 2009 | B2 |
7651990 | Asmus | Jan 2010 | B2 |
7670615 | Veeger et al. | Mar 2010 | B2 |
7683018 | Koivisto et al. | Mar 2010 | B2 |
7723279 | Lestage et al. | May 2010 | B2 |
7790663 | Lestage et al. | Sep 2010 | B2 |
7803390 | Asmus et al. | Sep 2010 | B2 |
7842725 | Wegner et al. | Nov 2010 | B2 |
8058315 | Wegner et al. | Nov 2011 | B2 |
20020022660 | Jampani | Feb 2002 | A1 |
20020028187 | Nekludoff et al. | Mar 2002 | A1 |
20020039562 | Kobayashi et al. | Apr 2002 | A1 |
20020098159 | Wei et al. | Jul 2002 | A1 |
20020108640 | Barger et al. | Aug 2002 | A1 |
20020127253 | Scholz et al. | Sep 2002 | A1 |
20020142018 | Scholz et al. | Oct 2002 | A1 |
20020151446 | Piterski et al. | Oct 2002 | A1 |
20020160029 | Asmus et al. | Oct 2002 | A1 |
20020160924 | Bertrem et al. | Oct 2002 | A1 |
20020177535 | Piterski et al. | Nov 2002 | A1 |
20020187908 | Gagilardi et al. | Dec 2002 | A1 |
20030134761 | Sebillotte-Arnaud et al. | Jul 2003 | A1 |
20030203824 | Staats | Oct 2003 | A1 |
20030211066 | Scholz et al. | Nov 2003 | A1 |
20030213542 | Kobayashi et al. | Nov 2003 | A1 |
20030215418 | Asmus et al. | Nov 2003 | A1 |
20030235550 | Pan et al. | Dec 2003 | A1 |
20040001797 | Saud et al. | Jan 2004 | A1 |
20040071748 | Asmus et al. | Apr 2004 | A1 |
20040072700 | Gupta | Apr 2004 | A1 |
20040102429 | Modak | May 2004 | A1 |
20040170592 | Veeger et al. | Sep 2004 | A1 |
20040191195 | Collins et al. | Sep 2004 | A1 |
20040191274 | Grayson et al. | Sep 2004 | A1 |
20040219227 | Modak et al. | Nov 2004 | A1 |
20040241099 | Popp et al. | Dec 2004 | A1 |
20040247685 | Modak et al. | Dec 2004 | A1 |
20040265240 | Tamarkin et al. | Dec 2004 | A1 |
20050003990 | Smith et al. | Jan 2005 | A1 |
20050031580 | Allef et al. | Feb 2005 | A1 |
20050031653 | Kwetkat et al. | Feb 2005 | A1 |
20050063925 | Candau et al. | Mar 2005 | A1 |
20050109981 | Tucker et al. | May 2005 | A1 |
20050129626 | Koivisto et al. | Jun 2005 | A1 |
20050152931 | SaNogueira et al. | Jul 2005 | A1 |
20050222001 | Baumeister et al. | Oct 2005 | A1 |
20050226838 | Krause et al. | Oct 2005 | A1 |
20050277574 | Niedbala et al. | Dec 2005 | A1 |
20060018847 | Kroepke et al. | Jan 2006 | A1 |
20060104911 | Novak | May 2006 | A1 |
20060104919 | Novak | May 2006 | A1 |
20060110416 | Ryles et al. | May 2006 | A1 |
20060121071 | Asmus | Jun 2006 | A1 |
20060165627 | Allef et al. | Jul 2006 | A1 |
20060182690 | Veeger | Aug 2006 | A1 |
20060198859 | Allef et al. | Sep 2006 | A1 |
20060204468 | Allef et al. | Sep 2006 | A1 |
20060257334 | Dahms et al. | Nov 2006 | A1 |
20060263396 | Asmus | Nov 2006 | A1 |
20060275226 | Dahms et al. | Dec 2006 | A1 |
20060281663 | Asmus | Dec 2006 | A1 |
20070027055 | Koivisto et al. | Feb 2007 | A1 |
20070041927 | Blaeser et al. | Feb 2007 | A1 |
20070065383 | Fernandez de Castro et al. | Mar 2007 | A1 |
20070092470 | Allef et al. | Apr 2007 | A1 |
20070141007 | Glynn et al. | Jun 2007 | A1 |
20070148101 | Snyder et al. | Jun 2007 | A1 |
20070179207 | Fernandez de Castro et al. | Aug 2007 | A1 |
20070258911 | Fernandez de Castro et al. | Nov 2007 | A1 |
20080051312 | Lestage et al. | Feb 2008 | A1 |
20080108704 | Asmus et al. | May 2008 | A1 |
20080145320 | Wenk et al. | Jun 2008 | A1 |
20080207767 | Dobos | Aug 2008 | A1 |
20080293825 | Littau et al. | Nov 2008 | A1 |
20080305056 | Jenni et al. | Dec 2008 | A1 |
20090054521 | Herrwerth et al. | Feb 2009 | A1 |
20090098067 | Seidling et al. | Apr 2009 | A1 |
20090318570 | Veeger et al. | Dec 2009 | A1 |
20090326076 | Asmus | Dec 2009 | A1 |
20100022660 | Wegner et al. | Jan 2010 | A1 |
20100160415 | Koivisto et al. | Jun 2010 | A1 |
20100187263 | Lestage et al. | Jul 2010 | A1 |
20100210499 | Allef et al. | Aug 2010 | A1 |
20100234475 | Wegner et al. | Sep 2010 | A1 |
20100327013 | Asmus | Dec 2010 | A1 |
20100331411 | Asmus | Dec 2010 | A1 |
20110104079 | Snyder et al. | May 2011 | A1 |
20110110869 | Scholz et al. | May 2011 | A1 |
Number | Date | Country |
---|---|---|
2003203452 | Oct 2004 | AU |
2 323 780 | Apr 2001 | CA |
2534692 | Feb 2005 | CA |
2587086 | Aug 2005 | CA |
2 587 086 | Apr 2006 | CA |
28 52 593 | Jun 1979 | DE |
3306593 | Feb 1983 | DE |
33 06 593 | Sep 1983 | DE |
19523320 | Jan 1997 | DE |
695 12 841 | May 2000 | DE |
696 30 221 | Jul 2004 | DE |
69512841 | May 2005 | DE |
10 2004 050 211 | Apr 2006 | DE |
0160051 | Oct 1984 | EP |
0 160 051 | Nov 1985 | EP |
0213527 | Mar 1987 | EP |
0117889 | Nov 1987 | EP |
0 260 641 | Mar 1988 | EP |
0384126 | Jan 1990 | EP |
0 384 126 | Aug 1990 | EP |
0 689-767 | Jan 1996 | EP |
0689767 | Jan 1996 | EP |
0882446 | Dec 1998 | EP |
0990412 | Apr 2000 | EP |
1118655 | Jul 2001 | EP |
1 584 323 | Oct 2005 | EP |
1584323 | Oct 2005 | EP |
1 893 197 | Mar 2008 | EP |
1967576 | Sep 2008 | EP |
1811013 | Aug 2009 | EP |
1 010 874 | Jul 1979 | GB |
2010874 | Jul 1979 | GB |
11349418 | Dec 1999 | JP |
07285808 | Nov 2007 | JP |
9307250 | Oct 1991 | WO |
9300089 | Jan 1993 | WO |
WO 9307250 | Apr 1993 | WO |
9501384 | Jan 1995 | WO |
9503772 | Feb 1995 | WO |
9700667 | Jan 1997 | WO |
9700667 | Jan 1997 | WO |
9700668 | Jan 1997 | WO |
WO 9700668 | Jan 1997 | WO |
9920250 | Apr 1999 | WO |
0006107 | Feb 2000 | WO |
0047183 | Aug 2000 | WO |
02062936 | Aug 2002 | WO |
03028671 | Sep 2002 | WO |
WO 03028671 | Apr 2003 | WO |
03034994 | May 2003 | WO |
03053388 | Jul 2003 | WO |
2004000016 | Dec 2003 | WO |
2005030917 | Sep 2004 | WO |
05030917 | Apr 2005 | WO |
2005051341 | Jun 2005 | WO |
2005123012 | Jun 2005 | WO |
2005123012 | Dec 2005 | WO |
2006042588 | Apr 2006 | WO |
2006042588 | Apr 2006 | WO |
2006066888 | Jun 2006 | WO |
2006094387 | Sep 2006 | WO |
2006138111 | Dec 2006 | WO |
2007095008 | Aug 2007 | WO |
2008132621 | Nov 2008 | WO |
2010010475 | Jan 2010 | WO |
Number | Date | Country | |
---|---|---|---|
20100069505 A1 | Mar 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11312559 | Dec 2005 | US |
Child | 12624073 | US |